Welcome to our dedicated page for Fosun Internatio news (Ticker: FOSUY), a resource for investors and traders seeking the latest updates and insights on Fosun Internatio stock.
News about Fosun International Limited (FOSUY) covers a broad range of topics reflecting its activities as a global innovation-driven consumer group. Company announcements and media releases describe developments across pharmaceuticals and healthcare, cultural tourism and consumption, financial services, and insurance, as well as updates on its innovation and globalization strategy.
Investors and observers can find news on Fosun’s pharmaceutical and healthcare initiatives, including progress in innovative drugs, medical devices, and healthcare services under entities such as Fosun Pharma and Henlius. Releases highlight clinical and regulatory milestones, new therapeutic indications, and the use of artificial intelligence in areas such as drug development decision-making and clinical trial prediction.
Coverage also includes cultural tourism and consumption news, such as performance and expansion of Club Med resorts under Fosun Tourism Group, cultural events, and consumer-focused projects. In financial services and insurance, news items discuss developments at Fosun Insurance Portugal (Fidelidade), asset servicing activities in Europe, and strategic portfolio adjustments, including asset sales and retained businesses.
Another important theme in Fosun-related news is ESG and sustainability. Articles describe its ESG ratings, inclusion in sustainability indices and yearbooks, climate disclosure practices, and social responsibility programs such as the Rural Doctors Program and contributions to global malaria treatment. Governance and award recognitions, including honors from organizations like Corporate Governance Asia, also feature prominently.
For those following FOSUY, this news stream provides insight into how Fosun advances its stated strategy of "Innovation + Globalization", how its core subsidiaries perform, and how it integrates ESG considerations into its operations. Regularly reviewing these updates can help readers understand the group’s evolving business focus and corporate priorities.
Fosun International has successfully completed a USD888 million sustainability-linked syndicated loan, one of the largest of its kind for a Chinese privately-owned enterprise in 2024. The loan, initially launched in May with a first close of USD603 million, was followed by Greenshoe accessions. 25 banks participated in the syndicate, including both long-term partners and new lenders from various countries.
This loan is part of Fosun's flagship financing platform, continuing its annual tradition of 3-year syndicated loans since 2017, with sustainability-linked features incorporated since 2023. The successful completion demonstrates Fosun's strong support from both Chinese and foreign banks, as well as its commitment to ESG initiatives.
Fosun aims to continue implementing its core business-focused strategy, improve operating capabilities in advantageous industries, and optimize its debt structure and liquidity management for steady future development.
Fosun International (HKEX: 00656) has received an AA- HSI ESG Rating for two consecutive years, highlighting its strong sustainability performance. The company has been selected as a constituent stock of the Hang Seng Corporate Sustainability Benchmark Index for five consecutive years. Fosun outperformed 90% of global enterprises in four core areas: Corporate Governance, Environment, Consumer Issues, and Community Involvement and Development.
Fosun has established a robust ESG governance structure and management system, integrating sustainable development principles into its operations. The company has committed to peaking carbon emissions by 2028 and achieving carbon neutrality by 2050. Fosun is the only conglomerate in Greater China rated AA by MSCI ESG Ratings and outperformed 94% of its global peers in the S&P Global Corporate Sustainability Assessment. The company was also included in the FTSE4Good Index Series and ranked in the top 1% of S&P Global's Sustainability Yearbook 2024 (China Edition).
Fosun International (OTC: FOSUF) received a Hang Seng Indexes Sustainability Rating of AA- for two consecutive years and was selected as a constituent of the Hang Seng Corporate Sustainability Benchmark Index for five consecutive years. The company reported ESG scores outperforming 90% of global peers in Corporate Governance, Environment, Consumer Issues, and Community Involvement, and stated targets to peak carbon emissions by 2028 and achieve carbon neutrality by 2050. Fosun also highlighted third‑party recognitions: the only conglomerate in Greater China rated AA by MSCI, 94% outperformance in S&P Global Corporate Sustainability Assessment, inclusion in the S&P Sustainability Yearbook 2024, and consistent FTSE Russell ESG scores above the global industry average.
Fosun International, a global consumer group, reported its 2024 interim results, highlighting its focus on globalization, innovation, and asset-light operations. Chairman Guo Guangchang emphasized the company's commitment to building a consumer-centered group with predictable development and profits. Fosun's overseas revenue accounted for 47% of total revenue, with plans for further increase. The company reported revenue of RMB97.84 billion and profit attributable to owners of RMB720 million. Fosun is streamlining its business, adopting an asset-light strategy, and focusing on core industries to achieve investment-grade ratings. The Group's adjusted total debt-to-capital ratio was 50.2%, continuing a downward trend since 2020.
Fosun International reported its 1H2024 results, showing total revenue growth to RMB97.84 billion and industrial operation profit of RMB3.47 billion. Key highlights include:
- Four core subsidiaries generated 74% of total revenue at RMB72.17 billion
- Adjusted debt-to-capital ratio decreased to 50.2%
- Overseas revenue reached RMB45.87 billion, 47% of total
- R&D investment of RMB3.5 billion
- Asset-light operations expanded, with Club Med's self-owned resorts reduced to 15%
The company maintained its strategic focus on core businesses, innovation, and globalization while optimizing its asset portfolio and reducing leverage. Fosun aims to continue developing industry-leading companies and products in its advantageous sectors.
Guo Guangchang, Chairman of Fosun International, reaffirmed the company's commitment to its globalization strategy at the 2024 Semi-Annual Working Meeting. Fosun, with a 17-year history of global expansion, now operates in over 35 countries. In 2023, overseas revenue reached RMB89.2 billion, accounting for 45% of total revenue, with a 10-year CAGR of 55%.
Key global successes include Club Med, a major revenue source for Fosun Tourism Group, and Fosun Pharma's expansion into African markets. Shanghai Henlius, a Fosun Pharma subsidiary, has gained international recognition for innovative drugs. Fidelidade, an overseas member company, increased its premium percentage in overseas markets from 6% in 2017 to 33% in 2023.
Fosun International (HKEX: 00656) has been included in S&P Global's Sustainability Yearbook 2024 (China Edition) as a top 1% performer and recognized as an Industry Mover. This achievement reflects Fosun's continuous efforts in environmental, social, and governance (ESG) practices.
The company's S&P Global Corporate Sustainability Assessment (CSA) score increased from 56 points in 2022 to 68 points in 2023, outperforming 94% of its global peers. Fosun's inclusion in the top 1% required scoring within 1% of the industry's top-performing company and achieving at least 60 points.
Fosun has established a robust ESG management system, integrating sustainability requirements into its business operations. The company focuses on responding to national strategies, ensuring information security, promoting innovation, implementing 'dual carbon' goals, and protecting employee rights.
On July 7, 2024, Fosun International announced its inclusion in the "China ESG 2024 ESG Action Report" by the Financial Program Center of China Media Group. Evaluating 972 out of 6,471 listed companies, the report ranked Fosun 14th overall and first in the composite industry for its ESG efforts.
Fosun International has a robust ESG management system in place, integrating sustainable practices into its business operations. In 2023, it received several accolades, including an MSCI ESG rating of AA for three consecutive years and inclusion in the S&P Global's Sustainability Yearbook 2024 as an "Industry Mover." Fosun Pharma, a subsidiary, was also recognized for its ESG achievements.
These achievements underline Fosun's commitment to sustainable development, focusing on national strategies, technology innovation, and public welfare, despite challenging macroeconomic conditions.
On July 1, the China-Thailand Cultural Tourism Industry Summit took place in Bangkok, hosted by the Global Tourism Economy Research Centre and organized by the China Chamber of Tourism and the China Women's Chamber of Commerce. A Chinese delegation of over 200 business leaders attended to enhance China-Thailand cooperation in cultural tourism. Keynote speeches highlighted the potential for mutual prosperity and collaboration. Fosun International's Co-CEO Xu Xiaoliang emphasized leveraging global and local operations for industry innovation and new opportunities. Discussions focused on fostering China-Thailand cooperation and tourism growth.
With a strong historical presence in Thailand, Fosun's Club Med Phuket Resort has been a significant player since 1985. Thailand also emerged as a vital source market for Fosun's various destinations. Xu Xiaoliang shared insights into Fosun's innovative practices, including urban vacation, super destination, and cultural tourism commerce. The success of Atlantis Sanya and the expansion of Club Med Urban Oasis in China were underscored. Xu concluded by highlighting future plans for collaboration and cultural exchange between China and Thailand.
Noah Holdings (NYSE: NOAH, HKEX: 6686), a leading wealth management service provider, announced changes to its Board of Directors effective June 30, 2024. Dr. Zhiwu Chen retired, and Mr. Jinbo Yao resigned after a decade of service. Mr. David Zhang and Ms. Xiangrong Li have been appointed as Independent Directors. Ms. Li will be the new Chairwoman and join the Audit Committee along with Mr. Zhang. These appointments are expected to enhance Noah's governance and financial operations. Mr. Zhang brings extensive legal expertise, while Ms. Li has a strong background in financial management. Noah aims to maintain its commitment to high corporate governance standards through these changes.